Exhibit 99.6

James Hardie Industries plc
Condensed Consolidated Financial Statements
as of and for the Three Months Ended 30 June 2021





F-1


James Hardie Industries plc
Index

 Page






F-2


James Hardie Industries plc
Condensed Consolidated Balance Sheets
  (Millions of US dollars)(Unaudited)
30 June
2021
31 March
2021
Assets
Current assets:
Cash and cash equivalents$131.1 $208.5 
Restricted cash and cash equivalents5.0 5.0 
Restricted cash and cash equivalents - Asbestos82.1 104.9 
Restricted short-term investments - Asbestos26.3 26.6 
Accounts and other receivables, net338.0 333.2 
Inventories226.8 218.3 
Prepaid expenses and other current assets41.6 38.9 
Insurance receivable - Asbestos6.6 6.6 
Workers’ compensation - Asbestos1.6 1.6 
Total current assets859.1 943.6 
Property, plant and equipment, net1,373.2 1,372.3 
Operating lease right-of-use-assets48.8 46.4 
Finance lease right-of-use-assets2.5 2.7 
Goodwill212.7 209.3 
Intangible assets, net 175.8 173.9 
Insurance receivable - Asbestos40.8 42.9 
Workers’ compensation - Asbestos20.1 20.3 
Deferred income taxes874.5 906.8 
Deferred income taxes - Asbestos356.3 367.4 
Other assets3.4 3.4 
Total assets$3,967.2 $4,089.0 
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable and accrued liabilities$350.4 $307.0 
Accrued payroll and employee benefits72.1 112.5 
Operating lease liabilities8.3 7.8 
Finance lease liabilities1.0 1.0 
Accrued product warranties5.9 6.0 
Income taxes payable15.2 6.6 
Asbestos liability120.9 122.2 
Workers’ compensation - Asbestos1.6 1.6 
Dividends payable 303.7 
Other liabilities27.9 32.7 
Total current liabilities603.3 901.1 
Long-term debt936.8 858.6 
Deferred income taxes83.7 86.3 
Operating lease liabilities55.3 53.3 
Finance lease liabilities1.7 1.9 
Accrued product warranties32.9 33.6 
Income taxes payable6.2 4.7 
Asbestos liability980.1 1,013.6 
Workers’ compensation - Asbestos20.1 20.3 
Other liabilities60.4 54.8 
Total liabilities2,780.5 3,028.2 
Commitments and contingencies (Note 8)
Shareholders’ equity:
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 444,366,491 shares issued and outstanding at 30 June 2021 and 444,288,874 shares issued and outstanding at 31 March 2021231.5 231.4 
Additional paid-in capital229.4 224.6 
Retained earnings732.8 611.4 
Accumulated other comprehensive loss(7.0)(6.6)
Total shareholders’ equity1,186.7 1,060.8 
Total liabilities and shareholders’ equity$3,967.2 $4,089.0 


The accompanying notes are an integral part of these condensed consolidated financial statements.
F-3

James Hardie Industries plc
Condensed Consolidated Statements of Operations and Comprehensive Income
(Unaudited)


 Three Months Ended 30 June
(Millions of US dollars, except per share data)20212020
Net sales$843.3 $626.3 
Cost of goods sold535.5 406.8 
Gross profit307.8 219.5 
Selling, general and administrative expenses119.1 87.6 
Research and development expenses8.5 7.3 
Restructuring expenses 11.1 
Asbestos adjustments (gain) loss(2.8)63.7 
Operating income183.0 49.8 
Interest expense, net10.1 12.6 
Other expense (income)0.2 (0.2)
Income before income taxes172.7 37.4 
Income tax expense51.3 28.0 
Net income$121.4 $9.4 
Income per share:
Basic$0.27 $0.02 
Diluted$0.27 $0.02 
Weighted average common shares outstanding (Millions):
Basic444.3 443.1 
Diluted445.7 445.2 
Comprehensive income, net of tax:
Net income$121.4 $9.4 
Currency translation adjustments(0.4)25.2 
Comprehensive income$121.0 $34.6 






The accompanying notes are an integral part of these condensed consolidated financial statements.
F-4


James Hardie Industries plc
Condensed Consolidated Statements of Cash Flows
(Unaudited)
 Three Months Ended 30 June
(Millions of US dollars)20212020
Cash Flows From Operating Activities
Net income$121.4 $9.4 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization38.4 31.2 
Lease expense5.0 4.4 
Deferred income taxes28.2 9.1 
Stock-based compensation4.8 4.3 
Asbestos adjustments (gain) loss(2.8)63.7 
Excess tax benefits from share-based awards(0.3)— 
Other, net5.7 6.3 
Changes in operating assets and liabilities:
Accounts and other receivables(4.0)40.1 
Inventories(8.1)51.6 
Lease assets and liabilities, net(4.7)(4.9)
Prepaid expenses and other assets(2.7)(3.4)
Insurance receivable - Asbestos1.7 0.7 
Accounts payable and accrued liabilities42.6 (1.7)
Claims and handling costs paid - Asbestos(23.5)(25.6)
Income taxes payable9.7 13.1 
Other accrued liabilities(27.3)(9.1)
Net cash provided by operating activities$184.1 $189.2 
Cash Flows From Investing Activities
Purchases of property, plant and equipment$(43.4)$(27.1)
Capitalized interest(0.5)(2.4)
Proceeds from restricted short-term investments - Asbestos 23.2 
Net cash used in investing activities$(43.9)$(6.3)
Cash Flows From Financing Activities
Proceeds from credit facilities$110.0 $— 
Repayments of credit facilities(40.0)(130.0)
Proceeds from issuance of shares0.1 — 
Repayment of finance lease obligations and borrowings(0.2)(0.1)
Dividends paid(309.9)— 
Net cash used in financing activities$(240.0)$(130.1)
Effects of exchange rate changes on cash and cash equivalents, restricted cash and restricted cash - Asbestos$(0.4)$2.1 
Net (decrease) increase in cash and cash equivalents, restricted cash and restricted cash - Asbestos(100.2)54.9 
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at beginning of period318.4 185.8 
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at end of period$218.2 $240.7 
Non-Cash Investing and Financing Activities
Capital expenditures incurred but not yet paid$15.3 $3.6 




The accompanying notes are an integral part of these condensed consolidated financial statements.
F-5


James Hardie Industries plc
Condensed Consolidated Statements of Changes in Shareholders' Equity

Three Months Ended 30 June 2021
(Millions of US dollars)Common
Stock
Additional
Paid-in
Capital
Retained
Earnings
Accumulated
Other
Comprehensive Loss
Total
Balances as of 31 March 2021$231.4 $224.6 $611.4 $(6.6)$1,060.8 
Net income— — 121.4 — 121.4 
Other comprehensive loss— — — (0.4)(0.4)
Stock-based compensation0.1 4.7 — — 4.8 
Issuance of ordinary shares— 0.1 — — 0.1 
Balances as of 30 June 2021$231.5 $229.4 $732.8 $(7.0)$1,186.7 



Three Months Ended 30 June 2020
(Millions of US dollars)Common
Stock
Additional
Paid-in
Capital
Retained
Earnings
Accumulated
Other
Comprehensive Loss
Total
Balances as of 31 March 2020$230.6 $207.3 $659.5 $(62.1)$1,035.3 
Net income— — 9.4 — 9.4 
Other comprehensive gain— — — 25.2 25.2 
Stock-based compensation— 4.3 — — 4.3 
Balances as of 30 June 2020$230.6 $211.6 $668.9 $(36.9)$1,074.2 



























The accompanying notes are an integral part of these condensed consolidated financial statements.

F-6


James Hardie Industries plc
Notes to Condensed Consolidated Financial Statements

1.  Organization and Significant Accounting Policies
Nature of Operations
James Hardie Industries plc ("JHI plc") manufactures and sells fiber cement, fiber gypsum and cement-bonded building products for interior and exterior building construction applications, primarily in the United States, Australia, Europe, New Zealand, the Philippines and Canada.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the U.S. generally accepted accounting principles ("GAAP") for interim financial information. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. Interim financial results are not necessarily indicative of results anticipated for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, included in the Company’s Annual Report on Form 20-F for the fiscal year ended 31 March 2021 from which the prior year balance sheet information herein was derived. The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expense, and related disclosures. Actual results could differ from those estimates.
The condensed consolidated financial statements represent the financial position, results of operations and cash flows of JHI plc and its wholly-owned subsidiaries and variable interest entity (“VIE”). Unless the context indicates otherwise, JHI plc and its direct and indirect wholly-owned subsidiaries and VIE (as of the time relevant to the applicable reference) are collectively referred to as “James Hardie”, the “James Hardie Group” or the “Company”. All intercompany transactions have been eliminated in consolidation. In management’s opinion, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments considered necessary for a fair presentation of the results for the interim periods presented.
The Company has recorded on its balance sheet certain foreign assets and liabilities, including asbestos related assets and liabilities under the terms of the Amended and Restated Final Funding Agreement (“AFFA”), that are denominated in foreign currencies and subject to translation (foreign entities) or remeasurement (Asbestos Injuries Compensation Fund (“AICF”) entity and Euro denominated debt) into US dollars at each reporting date. Unless otherwise noted, the Company converts foreign currency denominated assets and liabilities into US dollars at the current spot rate at the end of the reporting period; while revenues and expenses are converted using an average exchange rate for the period. The Company records gains and losses on its Euro denominated debt which are economically offset by foreign exchange gains and losses on loans between subsidiaries, resulting in a net immaterial translation gain or loss which is recorded in the Selling, general and administrative expenses in the condensed consolidated statements of operations and comprehensive income.

F-7


James Hardie Industries plc
Notes to Condensed Consolidated Financial Statements (continued)

Summary of Significant Accounting Policies
During the three months ended 30 June 2021, there were no changes to our significant accounting policies as described in our Annual Report on Form 20-F for the fiscal year ended 31 March 2021.
Accounting Pronouncements

Recently adopted
In December 2019, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2019-12, Income taxes (Topic 740). The amendments in the standard are being issued to simplify the accounting for income taxes and are effective for fiscal years and interim periods within those fiscal years, beginning after 15 December 2020 with early adoption permitted. The Company adopted ASU No. 2019-12 starting with the fiscal year beginning 1 April 2021 and the adoption of this standard did not have a material impact on the Company's condensed consolidated financial statements.
Earnings Per Share
Basic earnings per share ("EPS") is calculated using net income divided by the weighted average number of common shares outstanding during the period. Diluted EPS is similar to basic EPS except that the weighted average number of common shares outstanding is increased to include the number of additional common shares calculated using the Treasury Method that would have been outstanding if the dilutive potential common shares, such as restricted stock units ("RSUs"), had been issued.
Basic and dilutive common shares outstanding used in determining net income per share are as follows:
 Three Months Ended 30 June
(Millions of shares)20212020
Basic common shares outstanding444.3 443.1 
Dilutive effect of stock awards1.4 2.1 
Diluted common shares outstanding445.7 445.2 
There were no potential common shares which would be considered anti-dilutive for the three months ended 30 June 2021 and 2020.

Potential common shares of 0.7 million and 0.5 million for the three months ended 30 June 2021 and 2020, respectively, have been excluded from the calculation of diluted common shares outstanding as they are considered contingent shares which are not expected to vest.

F-8


James Hardie Industries plc
Notes to Condensed Consolidated Financial Statements (continued)

2. Revenues
The following represents the Company's disaggregated revenues:
Three Months Ended 30 June 2021
(Millions of US dollars)North America
Fiber Cement
Asia Pacific
Fiber Cement
Europe Building
Products
Consolidated
Fiber cement revenues$577.1 $141.8 $20.7 $739.6 
Fiber gypsum revenues— — 103.7 103.7 
Total revenues$577.1 $141.8 $124.4 $843.3 
Three Months Ended 30 June 2020
(Millions of US dollars)North America
Fiber Cement
Asia Pacific
Fiber Cement
Europe Building
Products
Consolidated
Fiber cement revenues$451.8 $91.3 $10.1 $553.2 
Fiber gypsum revenues— — 73.1 73.1 
Total revenues$451.8 $91.3 $83.2 $626.3 

The process by which the Company recognizes revenues is consistent across each of the Company's reportable segments. Fiber cement and fiber gypsum revenues are primarily generated from the sale of siding and various boards used in internal and external applications, as well as accessories. Fiber gypsum revenues also includes the sale of cement-bonded boards in the Europe Building Products segment.
3.  Cash and Cash Equivalents, Restricted Cash and Restricted Cash - Asbestos
The following table provides a reconciliation of Cash and cash equivalents, Restricted cash and Restricted cash - Asbestos reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows:
(Millions of US dollars)30 June
2021
31 March
2021
Cash and cash equivalents$131.1 $208.5 
Restricted cash5.0 5.0 
Restricted cash - Asbestos82.1 104.9 
Total cash and cash equivalents, restricted cash and restricted cash - Asbestos$218.2 $318.4 
Restricted cash relates to an insurance policy which restricts the cash from general corporate purposes.
Restricted cash - Asbestos is restricted to the settlement of asbestos claims and for the payment of the operating costs of AICF.


F-9


James Hardie Industries plc
Notes to Condensed Consolidated Financial Statements (continued)

4.  Inventories
Inventories consist of the following components:
(Millions of US dollars)30 June
2021
31 March
2021
Finished goods$154.3 $149.9 
Work-in-process20.4 17.9 
Raw materials and supplies61.3 60.4 
Provision for obsolete finished goods and raw materials(9.2)(9.9)
Total inventories$226.8 $218.3 

5.  Long-Term Debt
(Millions of US dollars)30 June
2021
31 March
2021
Senior unsecured notes:
Principal amount 3.625% notes due 2026 (€400.0 million)
$476.0 $468.3 
Principal amount 5.000% notes due 2028400.0 400.0 
Total876.0 868.3 
Unsecured revolving credit facility70.0 — 
Unamortized debt issuance costs(9.2)(9.7)
Total Long-term debt$936.8 $858.6 
Weighted average interest rate of Long-term debt4.1 %4.3 %
Weighted average term of available Long-term debt4.3 years4.5 years
Fair value of Senior unsecured notes (Level 1)$910.7 $904.7 
At 30 June 2021, the Company had a total borrowing base capacity under the unsecured revolving credit facility of US$500.0 million with outstanding borrowings of US$70.0 million and US$7.0 million drawn letters of credit and bank guarantees leaving the Company with US$423.0 million of available borrowing capacity under the unsecured revolving credit facility.
At 30 June 2021, the Company was in compliance with all covenants contained in the senior unsecured notes and the unsecured revolving credit facility agreement.


F-10


James Hardie Industries plc
Notes to Condensed Consolidated Financial Statements (continued)

6.  Asbestos
In February 2007, the Company’s shareholders approved the AFFA, an agreement pursuant to which the Company provides long-term funding to the AICF.
Asbestos Adjustments
The following table sets forth the Asbestos adjustments included in the condensed consolidated statements of operations and comprehensive income:
 Three Months Ended 30 June
(Millions of US dollars)20212020
Foreign exchange (gain) loss on Asbestos net liabilities$(5.7)$62.2 
Loss on foreign currency forward contracts2.9 1.5 
Asbestos adjustments (gain) loss$(2.8)$63.7 
Claims Data
The following table shows the activity related to the numbers of open claims, new claims and closed claims during each of the past five years and the average settlement per settled claim and case closed:
 Three MonthsFor the Years Ended 31 March
  Ended
30 June 2021
20212020201920182017
Number of open claims at beginning of period360 393 332 336 352 426 
Number of new claims
Direct claims98 392 449 430 422 402 
Cross claims37 153 208 138 140 155 
Number of closed claims122 578 596 572 578 631 
Number of open claims at end of period373 360 393 332 336 352 
Average settlement amount per settled claimA$310,000A$248,000A$277,000A$262,000A$253,000A$224,000
Average settlement amount per case closedA$295,000A$225,000A$245,000A$234,000A$217,000A$168,000
Average settlement amount per settled claimUS$239,000US$178,000US$189,000US$191,000US$196,000US$168,000
Average settlement amount per case closedUS$227,000US$162,000US$167,000US$171,000US$168,000US$126,000
Under the terms of the AFFA, the Company has rights of access to actuarial information produced for AICF by the actuary appointed by AICF, which is currently KPMG Actuarial. The Company’s disclosures with respect to claims statistics are subject to it obtaining such information, however, the AFFA does not provide the Company an express right to audit or otherwise require independent verification of such information or the methodologies to be adopted by the approved actuary. As such, the Company relies on the accuracy and completeness of the information provided by AICF to the approved actuary and the resulting information and analysis of the approved actuary when making disclosures with respect to claims statistics.
 

F-11


James Hardie Industries plc
Notes to Condensed Consolidated Financial Statements (continued)

The following is a detailed rollforward of the Net Unfunded AFFA liability, net of tax, for the three months ended 30 June 2021:
(Millions of US dollars)  Asbestos   Liability   Insurance
Receivables
Restricted
Cash and Investments
Other
Assets
and Liabilities
Net Unfunded AFFA LiabilityDeferred Tax
Assets
Income
Tax
Payable
Net Unfunded AFFA Liability, net of tax
Opening Balance - 31 March 2021$(1,135.8)$49.5 $131.5 $(1.9)$(956.7)$367.4 $35.2 $(554.1)
Asbestos claims paid1
23.2 — (23.2)— — — — — 
AICF claims-handling costs incurred (paid)
0.3 — (0.3)— — — — — 
AICF operating costs paid - non claims-handling
— — (0.3)— (0.3)— — (0.3)
Insurance recoveries— (1.7)1.7 — — — — — 
Movement in income tax payable— — — — — (7.5)(27.3)(34.8)
Other movements— — (0.1)0.1 — 0.1 — 0.1 
Effect of foreign exchange11.3 (0.4)(0.9)— 10.0 (3.7)(0.6)5.7 
Closing Balance - 30 June 2021$(1,101.0)$47.4 $108.4 $(1.8)$(947.0)$356.3 $7.3 $(583.4)
____________
1Claims paid of US$23.2 million reflects A$30.1 million converted at the average exchange rate for the period based on the assumption that these transactions occurred evenly throughout the period.
AICF Funding
During fiscal year 2022, the Company will contribute A$328.2 million to AICF in quarterly installments, the first payment of A$82.0 million was made 1 July 2021.
For the three months ended 30 June 2021, the Company did not provide financial or other support to AICF that it was not previously contractually required to provide.
Free cash flow as defined in the AFFA, for the three months ended 30 June 2021 is US$205.8 million, which is equivalent to operating cash flows of US$184.1 million, plus adjustments of US$21.7 million.
Restricted Short-Term Investments
In October 2020, AICF invested A$35.0 million (US$26.3 million, based on the exchange rate at 30 June 2021) of its excess cash in time deposits which are classified as available-for-sale investments and reflected within Restricted short-term investments - Asbestos on the condensed consolidated balance sheet. These time deposits mature on 2 July 2021 and have a fixed interest rate of 0.59% per year.
AICF – NSW Government Secured Loan Facility
AICF may borrow, subject to certain conditions, up to an aggregate amount of A$320.0 million (US$240.7 million, based on the exchange rate at 30 June 2021). The AICF Loan Facility is guaranteed by the Former James Hardie Companies and is available to be drawn for the payment of claims through 1 November 2030, at which point, all outstanding borrowings must be repaid. Borrowings made under the AICF Loan Facility are classified as current, as AICF intends to repay the debt within one year. At 30 June 2021 and 31 March 2021, AICF had no amounts outstanding under the AICF Loan Facility.

F-12


James Hardie Industries plc
Notes to Condensed Consolidated Financial Statements (continued)

7.  Derivative Instruments
The Company uses derivatives for risk management purposes and does not engage in speculative activity. A risk management objective for the Company is to mitigate interest rate risk associated with the Company’s external credit facilities and foreign currency risk primarily with respect to forecasted transactions denominated in foreign currencies. The determination of whether the Company enters into a derivative transaction to achieve these risk management objectives depends on a number of factors, including an evaluation of the extent to which derivative instruments will achieve such risk management objectives of the Company.
Foreign Currency Forward Contracts
The Company’s foreign currency forward contracts are valued using models that maximize the use of market observable inputs including interest rate curves and both forward and spot prices for currencies and are categorized as Level 2 within the fair value hierarchy.
The following table sets forth the total outstanding notional amount and the fair value of the Company’s foreign currency forward contracts:
Fair Value as of
(Millions of US dollars)Notional Amount30 June 202131 March 2021
Derivatives not accounted for as hedges30 June 202131 March 2021AssetsLiabilitiesAssetsLiabilities
Foreign currency forward contracts$286.1 $456.1 $4.2 $2.8 $5.5 $8.3 
The following table sets forth the gain and loss on the Company’s foreign currency forward contracts recorded in the Company's condensed consolidated statements of operations and comprehensive income as follows:
30 June
(Millions of US dollars)20212020
Asbestos adjustments loss$2.9 $1.5 
Selling, general and administrative expenses (income)(5.6)— 
Total (gain) loss on foreign currency forward contracts$(2.7)$1.5 
8.  Commitments and Contingencies
Legal Matters
The Company is involved from time to time in various legal proceedings and administrative actions related to the normal conduct of its business, including general liability claims, putative class action lawsuits and litigation concerning its products.
Although it is impossible to predict the outcome of any pending legal proceeding, management believes that such proceedings and actions should not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows, except as they relate to asbestos and New Zealand product liability claims as described in these condensed consolidated financial statements.

F-13


James Hardie Industries plc
Notes to Condensed Consolidated Financial Statements (continued)

New Zealand Weathertightness Claims

Since fiscal year 2002, the Company’s New Zealand subsidiaries have been joined in a number of weathertightness claims in New Zealand that relate to residential buildings (single dwellings and apartment complexes) and a small number of non-residential buildings, primarily constructed from 1998 to 2004. The claims often involve multiple parties and allege that losses were incurred due to excessive moisture penetration of the buildings’ structures. The claims typically include allegations of poor building design, inadequate certification of plans, inadequate construction review and compliance certification and deficient work by sub-contractors.

Historically, the Company’s New Zealand subsidiaries have been joined to these claims as one of several co-defendants, including local government entities responsible for enforcing building codes and practices, resulting in the Company’s New Zealand subsidiaries becoming liable for only a portion of each claim. In addition, the Company’s New Zealand subsidiaries have had access to third-party recoveries to defray a portion of the costs incurred in resolving such claims.

In 2015, the Company and/or its subsidiaries were named as the sole defendants in four claims on behalf of multiple defendants, three of which are still pending and each of which allege that the New Zealand subsidiaries’ products were inherently defective. The Company believes it has substantial factual and legal defenses to these claims and is defending the claims vigorously.

White, et al. (Case No. CIV-2015-404-2981 [2021] NZHC 930), In the High Court of New Zealand, Auckland Registry (hereinafter the “White litigation”). The trial of phase one of the White litigation commenced on 17 May 2021 in Auckland, New Zealand solely to determine whether the Company’s New Zealand subsidiaries, along with three non-New Zealand Group entities, had a duty to the plaintiffs and breached that duty. On 3 August 2021, the parties entered a final settlement of all claims, resulting in the plaintiffs' voluntary dismissal of the matter with prejudice, a payment of NZ$1.25 million to the Company by the party that funded the plaintiffs' litigation and no admission of liability by the Company.

Cridge, et al. (Case Nos. CIV-2015-485-594 and CIV-2015-485-773), In the High Court of New Zealand, Wellington Registry (hereinafter the “Cridge litigation”). In August 2020, trial of phase one of the Cridge litigation commenced in Wellington, New Zealand solely to determine whether the Company’s New Zealand subsidiaries had a duty to the plaintiffs and breached that duty. This phase of the trial concluded in December 2020, and a decision by the Wellington High Court is expected to be announced in the second quarter of FY 2022. We believe we have substantial factual and legal defenses to the claims in the Cridge litigation. While an unfavorable outcome in this phase is possible as litigation is inherently unpredictable, management does not believe that the outcome of this phase of the litigation will have a material adverse effect on the Company’s financial position. As of 30 June 2021, the Company has not recorded a reserve related to the Cridge litigation as the chance of loss is not probable and the amount of loss, if any, cannot be reasonably estimated. If an adverse decision is reached by the Wellington High Court, certain factors anticipated to be included in the decision may allow the Company to estimate a reasonable range of liability in the Cridge litigation.

Waitakere, et al. (Case No. CIV-2015-404-3080), In the High Court of New Zealand, Auckland Registry (hereinafter the “Waitakere litigation”). The trial in the Waitakere litigation is currently not scheduled to begin until May 2023 in Auckland, New Zealand. As of 30 June 2021, the Company has not recorded a reserve related to the Waitakere litigation as the chance of loss is not probable and the amount of loss, if any, cannot be reasonably estimated.


F-14


James Hardie Industries plc
Notes to Condensed Consolidated Financial Statements (continued)

The resolution of one or more of the litigation matters by way of a court decision or settlement has the potential to impact the accounting treatment regarding the probability of a potential loss and the Company’s ability to reasonably estimate a reserve with regards to the other litigation matters discussed above. Furthermore, an adverse judgement in one or more of these litigation matters could have a material adverse impact on our consolidated financial position, results of operations or cash flows.
Environmental and Legal
The operations of the Company, like those of other companies engaged in similar businesses, are subject to several laws and regulations on air and water quality, waste handling and disposal. The Company’s policy is to accrue for environmental costs when it is determined that it is probable that an obligation exists and the amount can be reasonably estimated.
9.  Income Taxes

Income taxes payable represents taxes currently payable which are computed at statutory income tax rates applicable to taxable income derived in each jurisdiction in which the Company conducts business. During the three months ended 30 June 2021, the Company paid taxes, net of refunds, of US$2.6 million.

Income tax expense differs from the statutory rate primarily due to the Company’s mix of pre-tax income by jurisdiction, foreign taxes on domestic income and foreign exchange on asbestos.

Deferred income taxes include net operating loss carry-forwards. At 30 June 2021, the Company had tax loss carry-forwards in Australia, New Zealand, Europe and the US of approximately US$61.1 million that are available to offset future taxable income in the respective jurisdiction. The Company establishes a valuation allowance against a deferred tax asset if it is more likely than not that some portion or all of the deferred tax asset will not be realized.

The Australian tax loss carry-forwards primarily result from current and prior year tax deductions for contributions to AICF. James Hardie 117 Pty Limited, the performing subsidiary under the AFFA, is able to claim a tax deduction for its contributions to AICF over a five-year period commencing in the year the contribution is incurred. At 30 June 2021, the Company recognized a tax deduction of US$25.1 million (A$32.5 million) for the current year relating to total contributions to AICF of US$467.4 million (A$651.0 million) incurred in tax years 2018 through 2021.
10.  Stock-Based Compensation
Total stock-based compensation expense consists of the following:
 Three Months Ended 30 June
(Millions of US dollars)20212020
Liability Awards$5.6 $6.8 
Equity Awards4.8 4.3 
Total stock-based compensation expense$10.4 $11.1 
As of 30 June 2021, the unrecorded future stock-based compensation expense related to outstanding equity awards was US$21.4 million and will be recognized over an estimated weighted average amortization period of 1.8 years.

F-15


James Hardie Industries plc
Notes to Condensed Consolidated Financial Statements (continued)

11.  Segment Information
The Company reports its operating segment information in the format that the operating segment information is available to and evaluated by the Chief Operating Decision Maker. The North America Fiber Cement segment manufactures fiber cement interior linings, exterior siding products and related accessories in the United States; these products are sold primarily in the United States and Canada. The Asia Pacific Fiber Cement segment includes all fiber cement products manufactured in Australia and the Philippines, and sold in Australia, New Zealand, Asia, the Middle East and various Pacific Islands. The Europe Building Products segment includes fiber gypsum and cement-bonded boards manufactured in Europe and fiber cement product manufactured in the United States that is sold in Europe. The Research and Development segment represents the cost incurred by the research and development centers. General Corporate primarily consist of Asbestos adjustments, officer and employee compensation and related benefits, professional and legal fees, administrative costs and rental expense, net of rental income, on the Company’s corporate offices. The Company does not report net interest expense for each segment as the segments are not held directly accountable for interest expense.
 Net Sales
Three Months Ended 30 June
(Millions of US dollars)20212020
North America Fiber Cement$577.1 $451.8 
Asia Pacific Fiber Cement141.8 91.3 
Europe Building Products124.4 83.2 
Worldwide total$843.3 $626.3 
 Operating Income
Three Months Ended 30 June
(Millions of US dollars)20212020
North America Fiber Cement$169.3 $128.4 
Asia Pacific Fiber Cement38.8 18.9 
Europe Building Products16.3 (2.7)
Research and Development(8.4)(6.1)
Segments total216.0 138.5 
General Corporate(33.0)(88.7)
Total operating income183.0 49.8 


F-16


James Hardie Industries plc
Notes to Condensed Consolidated Financial Statements (continued)

Research and development expenditures are expensed as incurred and are summarized by segment in the following table. Research and development segment operating income also includes Selling, general and administrative expenses of US$1.6 million and US$0.8 million during the three months ended 30 June 2021 and 2020, respectively.
Research and Development Expenses
 Three Months Ended 30 June
(Millions of US dollars)20212020
North America Fiber Cement$1.1 $1.1 
Asia Pacific Fiber Cement0.4 0.3 
Europe Building Products0.2 0.6 
Research and Development6.8 5.3 
Worldwide total$8.5 $7.3 

12.  Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss is comprised of the following at 30 June 2021:
(Millions of US dollars)Cash Flow
Hedges
Pension
Actuarial Gain
Foreign
Currency
Translation
Adjustments
Total
Balance at 31 March 2021$0.2 $0.4 $(7.2)$(6.6)
Other comprehensive loss— — (0.4)(0.4)
Balance at 30 June 2021$0.2 $0.4 $(7.6)$(7.0)

F-17